ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,048 filers reported holding ASTRAZENECA PLC in Q1 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $311,682 | +15.1% | 3,996 | 0.0% | 0.10% | +16.7% |
| Q1 2024 | $270,758 | +1.2% | 3,996 | +0.6% | 0.09% | 0.0% |
| Q4 2023 | $267,510 | -0.6% | 3,971 | -0.1% | 0.09% | -7.2% |
| Q3 2023 | $269,252 | -13.3% | 3,975 | -8.3% | 0.10% | -7.6% |
| Q2 2023 | $310,411 | +3.1% | 4,337 | 0.0% | 0.10% | +6.1% |
| Q1 2023 | $301,043 | +3.0% | 4,337 | +0.6% | 0.10% | +7.6% |
| Q4 2022 | $292,146 | +9.4% | 4,309 | -11.6% | 0.09% | +1.1% |
| Q3 2022 | $267,000 | -16.8% | 4,873 | +0.3% | 0.09% | -5.2% |
| Q2 2022 | $321,000 | -1.2% | 4,858 | -0.8% | 0.10% | +11.6% |
| Q1 2022 | $325,000 | +14.4% | 4,898 | +0.6% | 0.09% | +14.7% |
| Q4 2021 | $284,000 | -2.7% | 4,868 | 0.0% | 0.08% | -7.4% |
| Q3 2021 | $292,000 | +0.3% | 4,868 | +0.3% | 0.08% | +3.8% |
| Q2 2021 | $291,000 | +20.7% | 4,852 | 0.0% | 0.08% | +18.2% |
| Q1 2021 | $241,000 | – | 4,852 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |